Summaries
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
Early identification and referral of liver disease in infants
This Guidelines summary is based on guidance included within the Children’s Liver Disease Foundation Yellow Alert Pack, written to provide general guidelines on the early identification of liver disease in infants and their referral where appropriate.
BSG liver blood tests guideline
This summary covers the key points for GPs to consider when interpreting results from liver blood tests and how to respond to detected abnormalities.
NICE non-alcoholic fatty liver disease guideline
A summary of NICE guidance on non-alcoholic fatty liver disease. Includes identification, lifestyle advice, and pharmacological treatment.
NICE cirrhosis guideline
A useful and concise summary on the assessment and management of cirrhosis. Recommendations cover diagnosis, monitoring, and managing complications.
Test and reflect
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
Early identification and referral of liver disease in infants
BSG liver blood tests guideline
NICE non-alcoholic fatty liver disease guideline
Nurses play a crucial role in reducing the burden of liver disease